Harrow Will Release Third Quarter 2023 Financial Results on November 13, 2023
30 Ottobre 2023 - 1:00PM
Business Wire
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical
company, today announced that it will release its financial results
for the third quarter ended September 30, 2023, on Monday, November
13, 2023, after the market close. The Company will also post its
third quarter Letter to Stockholders to the “Investors” section of
its website, harrow.com. Harrow will host a conference call and
live webcast at 4:45 p.m. Eastern Time to discuss the results and
provide a business update.
Conference Call Details:
Date:
Monday, November 13, 2023
Time:
4:45 p.m. Eastern time
Participant Dial-in:
1-833-953-2434 (U.S.) 1-412-317-5763
(International)
Replay Dial-in (Passcode
7225453):
(telephonic replay through November 20,
2023)
1-877-344-7529 (U.S.) 1-412-317-0088
(International)
Webcast: (online replay through
November 13, 2024)
harrow.com
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical
company engaged in the discovery, development, and
commercialization of innovative ophthalmic pharmaceutical products
for the U.S. market. Harrow helps U.S. eyecare professionals
preserve the gift of sight by making its comprehensive portfolio of
prescription and non-prescription pharmaceutical products
accessible and affordable to millions of Americans each year. For
more information about Harrow, please visit harrow.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231030960332/en/
Jamie Webb Director of Communications and Investor Relations
jwebb@harrowinc.com 615-733-4737
Grafico Azioni Harrow (NASDAQ:HROW)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Harrow (NASDAQ:HROW)
Storico
Da Mag 2023 a Mag 2024
